ART5803

DB18379InvestigationalProtein Based Therapies

ART5803 is a humanized one-armed monoclonal antibody with a high affinity for the NMDA receptor.

Mechanism: Pharmacologically active on Glutamate receptor ionotropic, NMDA 1
Curator reviewed
Code names: ART-5803

Resolves to

Targets

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with ART5803, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.